Furthermore, we found that the enhanced proliferation and metastasis capacity of ESCC cells brought about by S100A7 overexpression or treatment with exogenous S100A7 could be moderated by pretreatment with RAGE inhibitors, which suggested the presence of an S100A7‐RAGE autocrine loop. This evidence concerns the gene S100A7 and esophageal squamous cell carcinoma.